219 related articles for article (PubMed ID: 23726764)
21. Serum amyloid A level is increased in neuromyelitis optica and atypical multiple sclerosis with smaller T2 lesion volume in brain MRI.
Yokote H; Yagi Y; Watanabe Y; Amino T; Kamata T; Mizusawa H
J Neuroimmunol; 2013 Jun; 259(1-2):92-5. PubMed ID: 23566403
[TBL] [Abstract][Full Text] [Related]
22. The prevalence of long spinal cord lesions and anti-aquaporin 4 antibodies in neuromyelitis optica patients in Taiwan.
Wang KC; Tsai CP; Lee CL; Chen SY; Chen SJ
Eur Neurol; 2011; 65(2):99-104. PubMed ID: 21273778
[TBL] [Abstract][Full Text] [Related]
23. Association of circulating follicular helper T cells with disease course of NMO spectrum disorders.
Li YJ; Zhang F; Qi Y; Chang GQ; Fu Y; Su L; Shen Y; Sun N; Borazanci A; Yang C; Shi FD; Yan Y
J Neuroimmunol; 2015 Jan; 278():239-46. PubMed ID: 25468778
[TBL] [Abstract][Full Text] [Related]
24. OSMS is NMO, but not MS: proven clinically and pathologically.
Weinshenker BG; Wingerchuk DM; Nakashima I; Fujihara K; Lennon VA
Lancet Neurol; 2006 Feb; 5(2):110-1. PubMed ID: 16426985
[No Abstract] [Full Text] [Related]
25. Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica.
Kuroda H; Fujihara K; Takano R; Takai Y; Takahashi T; Misu T; Nakashima I; Sato S; Itoyama Y; Aoki M
J Neuroimmunol; 2013 Jan; 254(1-2):178-82. PubMed ID: 23017732
[TBL] [Abstract][Full Text] [Related]
26. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
[TBL] [Abstract][Full Text] [Related]
27. Prediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)-6 produced during remission phase.
Barros PO; Cassano T; Hygino J; Ferreira TB; Centurião N; Kasahara TM; Andrade RM; Linhares UC; Andrade AF; Vasconcelos CC; Alvarenga R; Marignier R; Bento CA
Clin Exp Immunol; 2016 Mar; 183(3):480-9. PubMed ID: 26472479
[TBL] [Abstract][Full Text] [Related]
28. [Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].
Misu T; Takahashi T; Nakashima I; Fujihara K; Itoyama Y
Rinsho Byori; 2009 Mar; 57(3):262-70. PubMed ID: 19363997
[TBL] [Abstract][Full Text] [Related]
29. Iron deposition of the deep grey matter in patients with multiple sclerosis and neuromyelitis optica: a control quantitative study by 3D-enhanced susceptibility-weighted angiography (ESWAN).
Chen X; Zeng C; Luo T; Ouyang Y; Lv F; Rumzan R; Wang Z; Li Q; Wang J; Hou H; Huang F; Li Y
Eur J Radiol; 2012 Apr; 81(4):e633-9. PubMed ID: 22280874
[TBL] [Abstract][Full Text] [Related]
30. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
[TBL] [Abstract][Full Text] [Related]
31. Increased serum matrix metalloproteinase-9 in neuromyelitis optica: implication of disruption of blood-brain barrier.
Hosokawa T; Nakajima H; Doi Y; Sugino M; Kimura F; Hanafusa T; Takahashi T
J Neuroimmunol; 2011 Jul; 236(1-2):81-6. PubMed ID: 21621856
[TBL] [Abstract][Full Text] [Related]
32. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.
Bradl M; Misu T; Takahashi T; Watanabe M; Mader S; Reindl M; Adzemovic M; Bauer J; Berger T; Fujihara K; Itoyama Y; Lassmann H
Ann Neurol; 2009 Nov; 66(5):630-43. PubMed ID: 19937948
[TBL] [Abstract][Full Text] [Related]
33. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
Brück W; Popescu B; Lucchinetti CF; Markovic-Plese S; Gold R; Thal DR; Metz I
Ann Neurol; 2012 Sep; 72(3):385-94. PubMed ID: 23034911
[TBL] [Abstract][Full Text] [Related]
34. The ex vivo production of IL-6 and IL-21 by CD4+ T cells is directly associated with neurological disability in neuromyelitis optica patients.
Linhares UC; Schiavoni PB; Barros PO; Kasahara TM; Teixeira B; Ferreira TB; Alvarenga R; Hygino J; Vieira MM; Bittencourt VC; Andrade RM; Andrade AF; Bento CA
J Clin Immunol; 2013 Jan; 33(1):179-89. PubMed ID: 22948743
[TBL] [Abstract][Full Text] [Related]
35. HLA, PTPN22 and PD-1 associations as markers of autoimmunity in neuromyelitis optica.
Asgari N; Nielsen C; Stenager E; Kyvik KO; Lillevang ST
Mult Scler; 2012 Jan; 18(1):23-30. PubMed ID: 21908482
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the T cell receptor repertoire in the Japanese neuromyelitis optica: T cell activity is up-regulated compared to multiple sclerosis.
Warabi Y; Yagi K; Hayashi H; Matsumoto Y
J Neurol Sci; 2006 Nov; 249(2):145-52. PubMed ID: 16860825
[TBL] [Abstract][Full Text] [Related]
37. Increased T-cell immunity against aquaporin-4 and proteolipid protein in neuromyelitis optica.
Matsuya N; Komori M; Nomura K; Nakane S; Fukudome T; Goto H; Shiraishi H; Wandinger KP; Matsuo H; Kondo T
Int Immunol; 2011 Sep; 23(9):565-73. PubMed ID: 21795759
[TBL] [Abstract][Full Text] [Related]
38. Comparison of visual acuity and automated perimetry findings in patients with neuromyelitis optica or multiple sclerosis after single or multiple attacks of optic neuritis.
Fernandes DB; Ramos Rde I; Falcochio C; Apóstolos-Pereira S; Callegaro D; Monteiro ML
J Neuroophthalmol; 2012 Jun; 32(2):102-6. PubMed ID: 22157535
[TBL] [Abstract][Full Text] [Related]
39. Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients.
Içöz S; Tüzün E; Kürtüncü M; Durmuş H; Mutlu M; Eraksoy M; Akman-Demir G
Int J Neurosci; 2010 Jan; 120(1):71-5. PubMed ID: 20128675
[TBL] [Abstract][Full Text] [Related]
40. Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica.
Farrokhi M; Rezaei A; Amani-Beni A; Etemadifar M; Kouchaki E; Zahedi A
Acta Neurol Belg; 2015 Dec; 115(4):609-14. PubMed ID: 26008726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
